These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9036608)

  • 1. [A trial of using EHF therapy in patients with benign prostatic hyperplasia and its combination with chronic prostatitis].
    Loran OB; Dunaevskiĭ IaL; Segal AS
    Urol Nefrol (Mosk); 1996; (6):37-9. PubMed ID: 9036608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The joint use of hyperbaric oxygenation and EHF therapy in benign prostatic hyperplasia and its combination with chronic prostatitis].
    Loran OB; Dunaevskiĭ IaL; Vishnevskiĭ AE; Vashkevich VI
    Urol Nefrol (Mosk); 1997; (2):32-4. PubMed ID: 9206881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical effectiveness and safety study of combined therapy with an alpha-blocker and an anticholinergic for patients with LUT/BPH].
    Xiao H; Li HZ; Yang Y; Huang ZM; Li YQ; Zhao XF
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1590-3. PubMed ID: 17803845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study of Eviprostat for the treatment of benign prostatic hyperplasia].
    Song Y; Li NC; Wang XF; Ma LL; Wan B; Hong BF; Na YQ
    Zhonghua Nan Ke Xue; 2005 Sep; 11(9):674-6. PubMed ID: 16209208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cernilton in the treatment of prostatic adenoma and chronic prostatitis].
    Aslamazov EG; Akhvlediani ND; Vinarov AZ; Aliaev IuG
    Urologiia; 2007; (1):52, 54-6. PubMed ID: 17472001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of temporary prostatic obstruction after high-energy microwave thermothery by placement of prostatic bridge catheter].
    Djavan B; Seitz C; Fakhari M; Ghawidel K; Marberger M
    Prog Urol; 1999 Apr; 9(2):261-70. PubMed ID: 10370950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.
    Yang Y; Zhao XF; Li HZ; Wang W; Zhang Y; Xiao H; Zhang X
    Chin Med J (Engl); 2007 Mar; 120(5):370-4. PubMed ID: 17376305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Durability of 30-minute high-energy transurethral microwave therapy for treatment of benign prostatic hyperplasia: a study of 213 patients with and without urinary retention.
    Gravas S; Laguna P; Kiemeney LA; de la Rosette JJ
    Urology; 2007 May; 69(5):854-8. PubMed ID: 17482921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Optimal treatment of benign prostatic hyperplasia (BPH) with comorbid chronic prostatitis (category IIIA)].
    Golubchikov VA; Sitnikov NV; Kochetov AG; Perekhodov SN; Sidorov OV; Roiuk RV; Nagoprniuk VN; Tsibizov DN
    Urologiia; 2005; (4):9-12. PubMed ID: 16158737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A pilot study of photon therapy for benign prostate hyperplasia (a report of 30 cases)].
    Mo Z; Huang H; Long D; Yang Z
    Zhonghua Nan Ke Xue; 2004 Oct; 10(10):764-6, 770. PubMed ID: 15562792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study.
    Roehrborn CG; Siami P; Barkin J; Damião R; Becher E; Miñana B; Mirone V; Castro R; Wilson T; Montorsi F;
    Eur Urol; 2009 Feb; 55(2):461-71. PubMed ID: 19013011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photoselective vaporization of the prostate in the treatment of benign prostatic hyperplasia.
    Fu WJ; Hong BF; Yang Y; Cai W; Gao JP; Wang CY; Wang XX
    Chin Med J (Engl); 2005 Oct; 118(19):1610-4. PubMed ID: 16232345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of prostatic adenoma with concomitant chronic bacterial prostatitis].
    Davidov MI
    Urologiia; 2011; (1):21-8. PubMed ID: 21500490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A clinical analysis of benign prostatic hyperplasia with chronic prostatitis].
    Wu XJ; Yang LY; Zhang XZ
    Zhonghua Nan Ke Xue; 2008 Jun; 14(6):527-9. PubMed ID: 18649752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fushile: a safe and effective therapeutic for benign prostatic hyperplasia].
    Shang XJ; Liu ZY; Liu ZF; Sun YH; Huang YF
    Zhonghua Nan Ke Xue; 2008 Mar; 14(3):227-30. PubMed ID: 18488335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparative study on different doses of cernilton for preventing the clinical progression of benign prostatic hyperplasia].
    Xu J; Qian WQ; Song JD
    Zhonghua Nan Ke Xue; 2008 Jun; 14(6):533-7. PubMed ID: 18649754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: a prospective randomized multicenter study.
    Wagrell L; Schelin S; Nordling J; Richthoff J; Magnusson B; Schain M; Larson T; Boyle E; Duelund J; Kroyer K; Ageheim H; Mattiasson A
    Urology; 2004 Oct; 64(4):698-702. PubMed ID: 15491704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment outcome of tamsulosin for benign prostatic hyperplasia.
    Ichioka K; Ohara H; Terada N; Matsui Y; Yoshimura K; Terai A; Arai Y
    Int J Urol; 2004 Oct; 11(10):870-5. PubMed ID: 15479292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical efficacy of Naftopidil tablet in the treatment of benign prostatic hyperplasia].
    Ju XB; Wu HF; Su JT
    Zhonghua Nan Ke Xue; 2002; 8(4):286-8. PubMed ID: 12491697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
    Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
    Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.